GOODWILL AND INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2017

NOTE 3: GOODWILL AND INTANGIBLE ASSETS

On December 4, 2015, the Company completed the acquisition of NUVO Bank & Trust Company (“NUVO”), Springfield, Massachusetts. NUVO's banking business operates as a division of Merchants Bank. The acquisition resulted in goodwill of $7.01 million and core deposit intangible (“CDI”) of $1.38 million. The goodwill and intangible balances presented below resulted from the Company’s acquisition of NUVO.

Goodwill

Goodwill is deemed to have an indefinite life and therefore is not amortized, but is instead subject to impairment tests. There was no impairment for the three months ended March 31, 2017 or December 31, 2016.


	March 31,		December 31,
(In thousands)	2017		2016
Beginning of period	$	7,011	$	7,011
Acquired goodwill		—		—
Impairment		—		—
End of period	$	7,011	$	7,011

Other Intangible Assets

Acquired CDI were as follows:


	March 31, 2017						December 31, 2016
	Gross				Net		Gross				Net
	Carrying		Accumulated		Carrying		Carrying		Accumulated		Carrying
(In thousands)	Amount		Amortization		Amount		Amount		Amortization		Amount
Amortized intangible assets:
Core deposit intangible	$	1,377	$	(264)	$	1,113	$	1,377	$	(221)	$	1,156
Total	$	1,377	$	(264)	$	1,113	$	1,377	$	(221)	$	1,156

Aggregate amortization expense for the CDI was $43 thousand and $51 thousand for the three months ended March 31, 2017 and December 31, 2016, respectively.

The estimated amortization expense for each of the next five years:


(In thousands)		Amount
Remainder of 2017	$	130
2018		147
2019		126
2020		120
2021		120
2022		120
Thereafter		350

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details